C. Amiel

G. Carcelain, J. Savatovsky, H. Adle-Biassette, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

V. Calvez, C. Delaugerre, S. Yerly, 2017, The Journal of antimicrobial chemotherapy.

Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.

R. Tubiana, C. Katlama, F. Lescure, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Methicillin-resistant Staphylococcus aureus with the novel mecC gene variant isolated from a cat suffering from chronic conjunctivitis

S. Yerly, H. Fleury, D. Descamps, 2013 .

Post-transfusional anti-HCV-negative, non-A, non-B hepatitis. (I) a prospective clinical and epidemiological survey.

D. Valla, C. Blanc, C. Fretz, 1993, Journal of hepatology.

Virological failure of patients on maraviroc-based antiretroviral therapy.

C. Delaugerre, J. Izopet, P. Bellecave, 2015, The Journal of antimicrobial chemotherapy.

[Human granulocytic ehrlichiosis in Europe].

D. Choudat, C. Amiel, G. Abadia, 2004, Medecine et maladies infectieuses.

Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient.

C. Rabaud, T. May, L. Kures, 1998, The Journal of infection.

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.

V. Calvez, C. Charpentier, C. Delaugerre, 2015, The Journal of antimicrobial chemotherapy.

Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy

Y. Yazdanpanah, C. Maurage, B. Sablonnière, 2000, AIDS.

Hepatitis B escape mutant reactivation in a renal transplant patient.

G. Cuzon, J. Nicolas, H. Fontaine, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study

V. Calvez, C. Charpentier, C. Delaugerre, 2017, The Journal of antimicrobial chemotherapy.

Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients

Philippe Flandre, Vincent Calvez, Jacques Izopet, 2008, Antimicrobial Agents and Chemotherapy.

The impact of CCL3L1 copy number in an HIV-1-infected white population

F. Lescure, J. Poirier, G. Pialoux, 2010, AIDS.

High Variability of Plasma Drug Concentrations in Dual Protease Inhibitor Regimens

W. Rozenbaum, J. Poirier, G. Pialoux, 2003, Antimicrobial Agents and Chemotherapy.

New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies.

V. Calvez, C. Katlama, J. Spano, 2020, The Journal of infectious diseases.

Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells

S. Baconnais, S. Temam, P. Busson, 2010, Virology Journal.

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey.

P. Ambroise‐Thomas, C. Katlama, C. Leport, 1994, Medicine.

Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes

M. Labopin, M. Mohty, F. Giannotti, 2019, Bone Marrow Transplantation.

Uncommon Detection of Mixed HCV Genotype Infections in Recently Infected Men Who Have Sex with Men.

V. Calvez, C. Delaugerre, J. Molina, 2019, International journal of antimicrobial agents.

Shared HCV Transmission Networks among HIV-1 Positive and Negative Men Having Sex with Men by Ultra-Deep Sequencing

V. Calvez, C. Delaugerre, J. Molina, 2019, Journal of acquired immune deficiency syndromes.

Methyl-qPCR: a new method to investigate Epstein–Barr virus infection in post-transplant lymphoproliferative diseases

V. Maréchal, F. Quignon, E. Brissot, 2022, Clinical epigenetics.

Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases

V. Calvez, C. Katlama, N. Dupin, 2018, Journal of Clinical Microbiology.

Association of Killer Cell Immunoglobulin-Like Receptor Genes with Hodgkin's Lymphoma in a Familial Study

J. Nicolas, L. Abel, D. Middleton, 2007, PloS one.

Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies

G. Carcelain, X. Mariette, S. Pavy, 2009, Arthritis research & therapy.

A phase I study of a six-week cycle of immunotherapy with Murabutide in HIV-1 patients naive to antiretrovirals.

G. Bahr, D. Sissoko, Y. Mouton, 2003, Medical science monitor : international medical journal of experimental and clinical research.

Selective Regulation of Human Immunodeficiency Virus-Infected CD4+ Lymphocytes by a Synthetic Immunomodulator Leads to Potent Virus Suppression In Vitro and in hu-PBL-SCID Mice

G. Bahr, Y. Mouton, A. Capron, 2001, Journal of Virology.

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Targeted HIV Screening in Eight Emergency Departments: The DICI‐VIH Cluster‐Randomized Two‐Period Crossover Trial

G. Verbeke, I. Durand-zaleski, G. Hejblum, 2017, Annals of emergency medicine.

Clinical Tolerance and Immunologic Effects After Single or Repeated Administrations of the Synthetic Immunomodulator Murabutide in HIV‐1‐Infected Patients

G. Bahr, Y. Mouton, X. de la Tribonnière, 2002 .

Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients - evidence of non-exosomal transport

P. Busson, F. Guémira, M. Guerin, 2013, Virology Journal.

Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals

R. Tubiana, C. Katlama, O. Godin, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

V. Calvez, C. Charpentier, P. Bellecave, 2021, The Journal of antimicrobial chemotherapy.

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression.

C. Fagard, C. Rouzioux, F. Raffi, 2016, The Journal of antimicrobial chemotherapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Initiation of rilpivirine, tenofovir and emtricitabine (RPV/TDF/FTC) regimen in 363 patients with virological vigilance assessment in 'real life'.

G. Pialoux, V. Schneider, C. Amiel, 2014, The Journal of antimicrobial chemotherapy.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

V. Calvez, C. Charpentier, J. Izopet, 2019, The Journal of antimicrobial chemotherapy.

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.

V. Calvez, C. Delaugerre, S. Yerly, 2013, International journal of antimicrobial agents.

Mice Suppression In Vitro and in hu-PBL-SCID Immunomodulator Leads to Potent Virus Lymphocytes by a Synthetic + Immunodeficiency Virus-Infected CD 4 Selective Regulation of Human

A. Capron, G. Bahr, Y. Mouton, 2001 .

Positive Correlation between Epstein-Barr Virus Viral Load and Anti-Viral Capsid Immunoglobulin G Titers Determined for Hodgkin's Lymphoma Patients and Their Relatives

J. Nicolas, L. Abel, O. Hermine, 2006, Journal of Clinical Microbiology.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+patients

P. Canton, C. Amiel, C. Benassayag, 1992, Journal of endocrinological investigation.

Peripheral B cells with intracytoplasmic mu chains in HIV infection.

M. Béné, G. Faure, T. May, 1992, Clinical immunology and immunopathology.

L’ehrlichiose granulocytique humaine en Europe

D. Choudat, C. Amiel, G. Abadia, 2004 .

CD4‐like molecules in human sperm

G. Faure, C. Amiel, Jianqing Tang, 1990, FEBS letters.

[Prognostic factors of Pneumocystis carinii pneumonia in AIDS].

J. Viel, B. Hoen, T. May, 1996, Presse medicale.

Combined Linkage and Association Studies Show that HLA Class II Variants Control Levels of Antibodies against Epstein-Barr Virus Antigens

L. Abel, V. Pedergnana, A. Alcaïs, 2014, PloS one.

HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.

S. Yerly, B. Masquelier, H. Fleury, 2013, The Journal of antimicrobial chemotherapy.

LOW LEVEL OF BASELINE RESISTANCE IN RECENTLY HCV INFECTED MEN WHO HAVE SEX WITH MEN WITH HIGH-RISK BEHAVIORS.

V. Calvez, C. Delaugerre, J. Molina, 2021, Journal of global antimicrobial resistance.

Clinical tolerance and immunologic effects after single or repeated administrations of the synthetic immunomodulator murabutide in HIV-1-infected patients.

G. Bahr, Y. Mouton, X. de la Tribonnière, 2002, Journal of acquired immune deficiency syndromes.

Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count

F. Lescure, G. Pialoux, P. Callard, 2007, Journal of viral hepatitis.

Epstein-Barr virus load in whole blood correlates with HIV surrogate markers and lymphoma: a French national cross-sectional study.

C. Mengelle, C. Deback, S. Fafi-Kremer, 2009, Journal of acquired immune deficiency syndromes.

Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy.

J. Nicolas, Y. Richard, D. Mestivier, 2010, The Journal of infectious diseases.